MENU
ABOUT US
MAKE A DONATION
Login
SEARCH
CLOSE
Help Center
subscribe
newsletter
Newsstands
Epoch Shop
Gift
TOP NEWS
SPECIAL SERIES
SPECIAL COVERAGE
LATEST ARTICLES
US
US News
US Features
US Politics
US Crime News
New York
San Francisco
Los Angeles
Opinion
Thinking About China
Viewpoints
Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
The Reader’s Turn
China News
US-China Relations
Chinese Regime
Business & Economy
Chinese Culture
China Human Rights
Social Issues
Organ Harvesting in China
World News
Africa News
Americas
Asia & Pacific
Canada
Europe
UK News
Australia News
International
Middle East
Business & Markets
Companies
Economy
Markets
Real Estate
Gold and Commodities
ARTS & CULTURE
Fine Arts & Craftsmanship
Performing Arts
Books
Traditional Culture
Shen Yun Special Coverage
Film & TV
Science
News
Space
Environment
Tech
Tech News
Tech Products & Reviews
Social Media
Sports
Videos
American Thought Leaders
China Insider
Crossroads
Bright
Lifestyle
Inspired
Family & Education
Personal Finance
American Essence
Entertainment
Film & TV
Entertainment News
Health
Experts
Conditions
Life & Wellness
Special Topics
Battlefields
Search Text
SEARCH
EpochTV
US
US Politics
Opinion
World News
China
Hong Kong
Health
Bright
Arts
Falun Gong
Premium
Markets
Games
Livestream
More
Eli Lilly
EU Slaps Tariffs on Chinese EVs | Business Matters (Oct. 30)
The European Union has increased tariffs on Chinese-built electric vehicles to as much as 45.3 percent at the end of its highest-profile trade investigation that has divided Europe and prompted ...
October 30, 2024
BY
Don Ma
The Market Might As Well Close Every August
Commentary Every year, I wonder why the stock market doesn’t close in August since so many traders go ...
August 13, 2024
BY
Louis Navellier
JP Morgan: Recession Now More Likely; Average American Now Carrying Over $6,300 in Credit Card Debt | Business Matters Full Broadcast (Aug. 8)
JP Morgan is now raising the odds of a recession by the end of this year to 35 ...
August 8, 2024
BY
Don Ma
Eli Lilly to Sell Weight Loss Drugs Directly to Patients
The platform offers access to Mounjaro and Zepbound by connecting patients with telehealth professionals for evaluation.
January 8, 2024
BY
A.C. Dahnke
Eli Lilly Launches Digital Health Care Platform to Help Patients With Chronic Disease
The new digital health care platform facilitates home delivery for patients, ensuring they have 'consistent access' to Lilly ...
January 5, 2024
BY
Aldgra Fredly
Novo Nordisk Sues 2 Pharmacies for Allegedly Selling Adulterated Weight-Loss Drugs
The company said it conducted tests on compounded drugs that claim to contain semaglutide and found 'concerning levels ...
December 1, 2023
BY
Lorenz Duchamps
Safety Concerns Loom as Obesity Drugs Head to Clinical Trials in Kids as Young as 6
As childhood obesity rates surge globally, pharma giants test weight loss drugs on kids despite safety concerns over ...
November 1, 2023
BY
Mary Gillis
Eli Lilly Sues Clinics Over Alleged Sales of Unapproved Versions of Diabetes Drug
Pharmaceutical giant Eli Lilly has filed a lawsuit against multiple medical spas, wellness centers, and compounding pharmacies across ...
September 20, 2023
BY
Katabella Roberts
Top 5 US Pharma Companies Netted $82 Billion in 2022: Report
The five largest pharmaceutical companies in the United States netted approximately $81.9 billion last year, according to a ...
July 25, 2023
BY
Ryan Morgan
UK Public Agency Won’t Recommend Weight Loss Drug Mounjaro, Needs More Evidence
UK's health and social care watchdog has decided against recommending Mounjaro, Eli Lilly's weight loss drug for adults with diabetes. ...
June 28, 2023
BY
Harry Lee
Sen. Sanders Asks Insulin Manufacturers to Testify Before Senate HELP Panel
Senate Health, Education, Labor, and Pensions (HELP) Committee Chairman Bernie Sanders has called the executives of top insulin ...
April 21, 2023
BY
Joseph Lord
Major Drugmaker to Cut Insulin Prices for Americans
Eli Lilly and Co. announced on Wednesday that prices for the company's most commonly prescribed insulins will be ...
March 1, 2023
BY
Lorenz Duchamps
FDA Pulls Authorization for Eli Lilly’s COVID-19 Drug Bebtelovimab
Eli Lilly and Co.'s COVID-19 drug bebtelovimab is not currently authorized for emergency use in the United States, ...
December 3, 2022
BY
Reuters
Alzheimer’s Drug Breakthrough Big Boost for Roche, Eli Lilly
LONDON—The results of a key Alzheimer's drug trial on Wednesday have reignited decades-old hopes that targeting a particular ...
September 29, 2022
BY
Reuters
Eli Lilly Sued for Age Discrimination by US Agency EEOC
Eli Lilly and Co. was sued on Monday by the U.S. Equal Employment Opportunity Commission, which accused the ...
September 27, 2022
BY
Reuters
Major Drug Company Announces Change Over Indiana’s Abortion Ban
Pharmaceutical giant Eli Lilly said it is looking to expand its Indiana-based headquarters outside the state after Indiana ...
August 7, 2022
BY
Jack Phillips
FDA Rejects Eli Lilly’s China-Developed Cancer Drug
The U.S. Food and Drug Administration has declined to approve a lung cancer drug U.S. drugmaker Eli Lilly ...
March 25, 2022
BY
Frank Fang
FDA Restricts Use of 2 Monoclonal Antibody Treatments
The U.S. Food and Drug Administration (FDA) announced Jan. 24 it is restricting the use of two monoclonal ...
January 25, 2022
BY
Mimi Nguyen Ly
Judge Hears Opening Arguments on Biden Administration’s Alleged Purge of Industry From EPA Panels
Judge Timothy Kelly of the U.S. District Court for the District of Columbia heard opening arguments on Dec. ...
December 23, 2021
BY
Nathan Worcester
Lab Tests: Eli Lilly, Regeneron Antibody Therapies Lose out Against Omicron
FRANKFURT, GERMANY—German researchers have found that COVID-19 therapies developed by Eli Lilly and Regeneron lose most of their ...
December 16, 2021
BY
Reuters
FDA Authorizes Eli Lilly’s COVID-19 Antibody Therapy for Children
The Food and Drug Administration (FDA) on Friday expanded its emergency use authorization (EUA) of Eli Lilly and ...
December 3, 2021
BY
Mimi Nguyen Ly
FDA Grants Eli Lilly’s Experimental COVID-19 Antibody-Drug Emergency Use Authorization
Eli Lilly’s COVID-19 antibody-drug has been granted emergency use authorization by the Food and Drug Administration (FDA), widening ...
February 10, 2021
BY
Isabel van Brugen
FDA Gives Eli Lilly’s Experimental COVID-19 Antibody Drug Emergency Clearance
U.S. drug regulators granted Eli Lilly’s COVID-19 antibody drug an emergency-use authorization on Monday, widening access to a ...
November 10, 2020
BY
Isabel van Brugen
Antibody Treatment Shows Improvement in Patients With Mild to Moderate Infection
Eli Lilly’s neutralizing antibody LY-CoV555 has shown improvement in treating patients with mild to moderate cases of the CCP ...
October 30, 2020
BY
Paula Liu
NIH Announces Halt to Eli Lilly Antibody Treatment on Hospitalized COVID-19 Patients
The National Institute of Allergy and Infectious Diseases (NIAID) announced in a statement that they have stopped clinical trials of ...
October 27, 2020
BY
Paula Liu
Eli Lilly Pauses COVID-19 Drug Trial Due to Safety Concerns
Eli Lilly announced on Tuesday that the government-sponsored clinical trial of its COVID-19 monoclonal antibody treatment has been ...
October 14, 2020
BY
Tom Ozimek
Drugmaker Eli Lilly Caps Insulin Costs at $35 as CCP Virus Crisis Deepens
Drugmaker Eli Lilly & Co. announced on April 7 that it has rolled out a scheme to cap ...
April 8, 2020
BY
Isabel van Brugen
TOP NEWS
Trump Denounces Communism, Touts Trump Accounts for Children in Georgia Speech
NEW
By
Travis Gillmore
124 Swiss Lawmakers Condemn Beijing’s Transnational Repression of Falun Gong
NEW
By
Arthur Zhang
Live From Capitol Hill: ‘Unbroken’ Panel Discussion on Artistic Freedom
NEW
By
Epoch Video
The New Cholesterol Pill Isn’t for Everyone. Here’s How to Tell.
1hr
By
Sheramy Tsai
Senate Panel Advances Bill to Make Hospitals Compete on Price
2hr
By
Lawrence Wilson
House Adopts Budget Blueprint for $95 Billion Reconciliation Package
3hr
By
Jackson Richman
US Signs Nuclear Cooperation Deal With Saudi Arabia
3hr
By
Emel Akan
House Passes Defense Policy Bill That Attaches SAVE America Act
3hr
By
Jackson Richman
Allergy Medication Recalled Over Possible ‘Life-Threatening’ Risks
4hr
By
Jack Phillips
US, Ukraine Sign Agreement for Drone Testing
4hr
By
Jill McLaughlin